NTRR Explores Developing All-Natural Alternative to Adderall

  NTRR Explores Developing All-Natural Alternative to Adderall  Business Wire  TAMPA, Fla. -- July 24, 2014  In its mission to deliver all-natural, cutting-edge wellness solutions, Neutra Corp. (OTCBB: NTRR) is exploring the development of an herbal supplement alternative to the drug Adderall.  Adderall is an effective and widely-prescribed drug used to treat narcolepsy and ADHD. Like many prescription drugs, however, Adderall can be habit-forming and produce undesirable side-effects such as high blood pressure, tremors, hallucinations, nausea, sleep problems, anxiety and many more. By developing an over-the-counter supplement using only all-natural ingredients, NTRR believes it can provide a better solution.  “Our goal would be the development of a capsule that can provide many of the benefits of Adderall without the dangerous side-effects and potential for addiction,” said NTRR CEO Sydney Jim. “We’re currently seeking out potential development partners who can help us produce a new nutraceutical that can change the lives of people currently addressing various wellness issues with Adderall and other expensive prescriptions.”  Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing wellness sector alongside Herbalife Ltd. (NYSE:HLF),Vitamin Shoppe (NYSE:VSI), Nutraceutical International Corp. (NASDAQ:NUTR) andSchiff Nutrition International Inc. (NYSE:WNI).  About Neutra Corp.  Neutra Corp.is a healthy lifestyle company that specializes in the development and marketing of natural wellnesssolutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces. For investing information and performance data, please visitwww.neutracorp.com.  Notice Regarding Forward-Looking Statements  Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Suchforward-looking statementsinvolve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.  Contact:  Neutra Corp. Sydney Jim, 813-367-2041 President and CEO info@neutracorp.com  
Press spacebar to pause and continue. Press esc to stop.